CROs presently claim to possess the necessary capabilities to offer a wide range of preclinical

Given the complex R&D protocols and the increasing demand for clinical evidence of therapeutic benefit, there seems to be a lucrative opportunity for contract research providers engaged in the medical devices’ domain. In fact, since 2000, 150 new CROs have been established that offer a variety of cost-efficient services and solutions to medical device developers.

To order this 400+ page report, which features 240+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

The USD 15.7 billion (by 2030) financial opportunity within the antibody contract manufacturing market has been analyzed across the following segments:

• Phase of Development
• Clinical
• Preclinical

• Types of Preclinical Services Offered

• Biocompatibility testing
• Sterility and microbiology testing
• Material characterization and analytical services
• Others

• Types of Clinical Services Offered

• Clinical trial management
• Data management
• Regulatory affairs management
• Consulting
• Others

To request for customize report -  https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

• Device Class

• Class I medical devices
• Class II medical devices
• Class III medical devices

• Target Therapeutic Area
• CNS disorders
• Cardiovascular disorders
• Oncological disorders
• Bone disorders
• Respiratory disorders
• Pain management disorders
• Ophthalmic disorders
• Psychological disorders
• Metabolic disorders
• Others

• Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Rest of the World

The “Medical Device CRO Market (2^nd Edition), 2020-2030”. report features the following companies, which we identified to be key players in this domain:

• Avania (formerly known as Factory CRO)
• Charles River Laboratories
• Clinlogix
• CROMSOURCE
• CSSi LifeSciences™
• Eurofins Medical Device Testing
• genae
• IMARC Research
• IQVIA
• Medpace
• NAMSA
• Qserve Group
• Regulatory and Clinical Research Institute (now a part of Covance)
• WuXi AppTec

Table of Contents

1. Preface

2. Executive Summary

3. Introduction
 

4. Market Landscape
 

5. Regulatory and Reimbursement Landscape for medical devices
 

6. Company Profiles
 

7. Medical Device Developer and CRO Relationships: Key Value Drivers and Performance Indicators 
 

8. Competitive Benchmarking
 

9. Brand Positioning of Key Industry Players
 

10. Clinical Trial Analysis
 

11. Mergers and Acquisitions
 

12. Survey Insights
 

13. Market Sizing and Forecast
 

14. Case Study: Impact of Coronavirus Outbreak

15. SWOT Analysis

16. Future Trends and Opportunities

17. Interview Transcripts

18. Appendix 1: Tabulated Data

19. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

You may also be interested in the following titles:

1. Medical Device Contract Manufacturing Market, 2019-2030
2. Biologics Fill / Finish Services Market, 2019 – 2030  
3. Pre-Sterilized / Ready-to-Use Primary Packaging: Focus on Cartridges, Syringes and Vials, 2018-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Article source: https://article-realm.com/article/Health-Fitness/Exercise/15987-CROs-presently-claim-to-possess-the-necessary-capabilities-to-offer-a-wide-range-of-preclinical.html